Haemogram parameters predict tumor grade and prognosis in brain tumors
- 1 April 2026
- journal article
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (4) , 299-304
Abstract
Aim This study aimed to evaluate whether readily available haemogram parameters and their ratios can predict the grade and prognosis of glial brain tumors. Methods In this retrospective study, preoperative haemogram data of patients who underwent intracranial tumor surgery between 2007 and 2020 were analyzed. Blood samples collected within one week prior to surgery were evaluated. Statistical analyses were performed using SPSS 24. Normally distributed variables were analyzed with ANOVA, and non-normal variables with Kruskal–Wallis tests. Age was included as a covariate using ANCOVA due to its correlation with haemogram parameters. Categorical variables were analyzed using the chi-square test. Results A total of 462 patients were included. Lower hemoglobin levels and higher lymphocyte counts were associated with grade I tumors, whereas higher neutrophil counts and neutrophil-to-lymphocyte ratio (NLR) were associated with grade IV tumors. After adjustment for age, platelet count was significantly higher in grade IV compared to grade III. Lymphocyte levels remained significantly higher in grade I compared to other groups. Platelet-to-lymphocyte ratio (PLR), initially non-significant, showed significant differences between grade I, II, and IV after age adjustment. Conclusion Haemogram parameters may provide useful supplementary information in predicting tumor grade in glial brain tumors. These findings suggest that inexpensive and easily accessible blood markers could contribute to preoperative assessment and clinical decision-making. Larger, multicenter studies are needed to validate these results.This publication has 10 references indexed in Scilit:
- Survival rate of patient with glioblastoma: a population-based studyEgyptian Journal of Neurosurgery, 2024
- Can we Predict Preoperative Tumor Aggressivity with Hemogram Parameters in Renal Cell Carcinoma? a Novel Calculation MethodJournal of Medical Systems, 2019
- The Relation between Hemogram Parameters and Survival in Extensive-Stage Small Cell Lung CancerOncology Research and Treatment, 2019
- Platelet indices in non-small cell lung cancer patients with brain metastasesCancer Biomarkers, 2019
- The Surveillance, Epidemiology, and End Results (SEER) Program and PathologyAmerican Journal of Surgical Pathology, 2016
- Evaluation of simple blood counts as inflammation markers for brain tumor patientsNeurologia i Neurochirurgia Polska, 2016
- Evaluation of Two Inflammation-Based Prognostic Scores in Patients with Resectable Gallbladder CarcinomaAnnals of Surgical Oncology, 2013
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009Neuro-Oncology, 2012
- The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guidelineJournal of Neuro-Oncology, 2009
- Advances in Evaluation of Primary Brain TumorsSeminars in Nuclear Medicine, 2008